BJP College Seminars Series
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Psychiatric Bulletin Advances in Psychiatric Treatment All RCPsych Journals
QUICK SEARCH:   [advanced]


     

The British Journal of Psychiatry (1967) 113: 1431-1432. doi: 10.1192/bjp.113.505.1431
© 1967 The Royal College of Psychiatrists
This Article
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MILLAR, J.
Right arrow Articles by DANIEL, G. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MILLAR, J.
Right arrow Articles by DANIEL, G. R.

A Trial of Fluphenazine Enanthate in Chronic Schizophrenia

JOHN MILLAR M.B., Ch.B., D.P.M.1 and G. R. DANIEL M.B., B.S.2

1 Consultant Psychiatrist, Carlton Hayes Hospital, Narborough, Leicester
2 Medical Adviser, E. R. Squibb & Sons Limited, Regal House, Twickenham, Middlesex

In a clinical trial on in-patient chronic schizophrenics, fluphenazine enanthate controlled 82 per cent. of the patients when given in doses of 1 ml. (25 mg.) every two weeks for six months. Over 25 per cent. showed moderate or marked improvement over their previous clinical state when they were on oral phenothiazines. Four patients previously receiving oral fluphenazine were definitely improved, and this suggested that they had not been taking all their tablets. Anti-Parkinson drugs were required by only 33 per cent. of the controlled cases after four months' treatment. This is an effective and time-saving preparation for the majority of schizophrenic in-patients and likely to be a most useful drug for those out-patients who are unreliable at taking their medication.

Submitted on November 30, 1966




This article has been cited by other articles:


Home page
 Arch Gen PsychiatryHome page
J. E. Groves and M. R. Mandel
The Long-Acting Phenothiazines
Arch Gen Psychiatry, July 1, 1975; 32(7): 893 - 900.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Psychiatric Bulletin Advances in Psychiatric Treatment All RCPsych Journals
Copyright © 1967 The Royal College of Psychiatrists.